Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IRIX NASDAQ:LUCY NASDAQ:NRXS NYSE:RVP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRIXIRIDEX$1.34-2.2%$1.25$0.78▼$2.04$22.77M0.6390,251 shs81,468 shsLUCYInnovative Eyewear$1.90-1.6%$2.03$1.57▼$11.16$6.27M3.211.15 million shs151,260 shsNRXSNeurAxis$2.43+0.4%$2.52$1.33▼$6.20$23.99M3.1608,067 shs11,293 shsRVPRetractable Technologies$0.82+1.4%$0.75$0.56▼$0.94$24.61M1.458,336 shs35,503 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRIXIRIDEX+3.65%+3.79%+5.38%+45.73%-32.51%LUCYInnovative Eyewear-0.52%+3.21%-2.03%-21.22%-64.39%NRXSNeurAxis-0.82%-1.63%-2.81%+5.68%-21.94%RVPRetractable Technologies-1.10%+3.80%+0.25%+24.58%-10.34%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRIXIRIDEX$1.34-2.2%$1.25$0.78▼$2.04$22.77M0.6390,251 shs81,468 shsLUCYInnovative Eyewear$1.90-1.6%$2.03$1.57▼$11.16$6.27M3.211.15 million shs151,260 shsNRXSNeurAxis$2.43+0.4%$2.52$1.33▼$6.20$23.99M3.1608,067 shs11,293 shsRVPRetractable Technologies$0.82+1.4%$0.75$0.56▼$0.94$24.61M1.458,336 shs35,503 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRIXIRIDEX+3.65%+3.79%+5.38%+45.73%-32.51%LUCYInnovative Eyewear-0.52%+3.21%-2.03%-21.22%-64.39%NRXSNeurAxis-0.82%-1.63%-2.81%+5.68%-21.94%RVPRetractable Technologies-1.10%+3.80%+0.25%+24.58%-10.34%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIRIXIRIDEX 0.00N/AN/AN/ALUCYInnovative Eyewear 0.00N/AN/AN/ANRXSNeurAxis 3.00Buy$7.00188.07% UpsideRVPRetractable Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest LUCY, NRXS, RVP, and IRIX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy$7.00(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIRIXIRIDEX$49.74M0.46N/AN/A$0.13 per share10.31LUCYInnovative Eyewear$1.64M3.82N/AN/A$3.72 per share0.51NRXSNeurAxis$3.22M7.46N/AN/A($0.27) per share-9.00RVPRetractable Technologies$38.16M0.64$0.02 per share48.25$3.31 per share0.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIRIXIRIDEX-$8.91M-$0.33N/A∞N/A-10.95%-386.93%-17.42%11/11/2025 (Estimated)LUCYInnovative Eyewear-$7.77M-$2.78N/A∞N/A-390.70%-79.72%-74.86%N/ANRXSNeurAxis-$14.63M-$0.99N/A∞N/A-492.76%N/A-641.25%N/ARVPRetractable Technologies-$7.01M-$0.29N/A∞N/A-41.11%-17.15%-9.33%N/ALatest LUCY, NRXS, RVP, and IRIX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025LUCYInnovative Eyewear-$0.77-$0.66+$0.11-$0.66$1.00 million$0.58 million8/12/2025Q2 2025IRIXIRIDEX-$0.09-$0.06+$0.03-$0.06$13.10 million$13.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIRIXIRIDEXN/AN/AN/AN/AN/ALUCYInnovative EyewearN/AN/AN/AN/AN/ANRXSNeurAxisN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIRIXIRIDEX62.291.961.34LUCYInnovative EyewearN/A18.7015.46NRXSNeurAxisN/A0.240.23RVPRetractable Technologies0.018.575.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIRIXIRIDEX20.10%LUCYInnovative Eyewear0.96%NRXSNeurAxis11.77%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipIRIXIRIDEX7.40%LUCYInnovative Eyewear1.66%NRXSNeurAxis15.20%RVPRetractable Technologies57.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIRIXIRIDEX12016.99 million15.74 millionOptionableLUCYInnovative Eyewear93.30 million3.24 millionNot OptionableNRXSNeurAxis199.87 million6.09 millionNot OptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableLUCY, NRXS, RVP, and IRIX HeadlinesRecent News About These CompaniesHead-To-Head Contrast: Retractable Technologies (NYSE:RVP) versus Minerva Surgical (NASDAQ:UTRS)September 10 at 3:57 AM | americanbankingnews.comRetractable Technologies (NYSE:RVP) vs. Motus GI (NASDAQ:MOTS) Financial ComparisonSeptember 9 at 2:41 AM | americanbankingnews.comRetractable Technologies Stock Gains Following Q2 Earnings GrowthAugust 21, 2025 | zacks.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Acquires 32,935 Shares of StockAugust 20, 2025 | insidertrades.comRetractable Technologies Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comRetractable Technologies, Inc. Results for the Periods Ended June 30, 2025August 14, 2025 | businesswire.comRetractable Technologies, Inc. (NYSE:RVP) CEO Purchases $37,155.75 in StockAugust 12, 2025 | insidertrades.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $20,193.12 in StockAugust 1, 2025 | insidertrades.comRetractable Technologies, Inc. Announces Reduction in Its Manufacturing Workforce | RVP Stock NewsJuly 23, 2025 | gurufocus.comRetractable Technologies, Inc. Announces Reduction in Its Manufacturing WorkforceJuly 23, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Business WireJuly 2, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersJune 30, 2025 | businesswire.comRetractable technologies CEO Shaw buys $14,274 in RVP stockJune 20, 2025 | investing.comZacks Initiates Coverage of Retractable Technologies With Underperform RecommendationJune 19, 2025 | zacks.comRetractable Technologies, Inc. (NYSE:RVP) CEO Buys $14,313.42 in StockJune 19, 2025 | insidertrades.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $13,047.54 in StockJune 17, 2025 | insidertrades.comretractable technologies appoints new auditor after mergerJune 8, 2025 | investing.comThomas J. Shaw Buys 86,014 Shares of Retractable Technologies, Inc. (NYSE:RVP) StockMay 17, 2025 | insidertrades.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025 | RVP Stock NewsMay 15, 2025 | gurufocus.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025May 15, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLUCY, NRXS, RVP, and IRIX Company DescriptionsIRIDEX NASDAQ:IRIX$1.34 -0.03 (-2.19%) As of 03:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.Innovative Eyewear NASDAQ:LUCY$1.90 -0.03 (-1.61%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.NeurAxis NASDAQ:NRXS$2.43 +0.01 (+0.41%) As of 03:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.Retractable Technologies NYSE:RVP$0.82 +0.01 (+1.36%) As of 03:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Intel's Silent Comeback: 3 Pillars the Market Is Overlooking Palantir’s Defense Partnerships Fuel Its Growth Story It May Be Time to Buy the Dip in Texas Instruments Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
